Compare PEPG & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEPG | SRTA |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 472.4M |
| IPO Year | 2022 | N/A |
| Metric | PEPG | SRTA |
|---|---|---|
| Price | $6.72 | $4.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $11.67 | $7.63 |
| AVG Volume (30 Days) | 597.7K | ★ 746.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $37.89 |
| Revenue Next Year | N/A | $14.33 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.89 | $3.85 |
| 52 Week High | $7.80 | $6.02 |
| Indicator | PEPG | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 59.75 | 56.32 |
| Support Level | $4.36 | $4.78 |
| Resistance Level | $6.81 | $5.40 |
| Average True Range (ATR) | 0.60 | 0.27 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 70.57 | 84.62 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.